Genpact (NYSE: G) CEO sells 2,800 shares after option exercise

Rhea-AI Filing Summary

Genpact Ltd President and CEO Balkrishan Kalra reported multiple equity transactions. On March 4, 2026, he exercised an employee stock option for 2,800 common shares at $27.65 per share, then sold 2,800 common shares in an open‑market transaction at a weighted average price of $40.77, leaving 525,007 common shares held directly afterward.

On March 3, 2026, he also acquired 27,160 common shares as a grant or award at no cost, increasing his direct holdings. Footnotes note performance share units granted on March 15, 2023 that will vest on March 10, 2026, and 8,962 shares currently held under the employee stock purchase plan, including 587 shares bought since his prior Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalra Balkrishan

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/03/2026		A		27,160(1)	A	$0	525,007(2)	D
Common Shares	03/04/2026		M		2,800	A	$27.65	527,807	D
Common Shares	03/04/2026		S		2,800	D	$40.77(3)	525,007	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$27.65	03/04/2026		M			2,800	(4)	03/31/2026	Common Shares	2,800	$0	0	D

Explanation of Responses:

1. The reporting person was granted performance share units (PSUs) on March 15, 2023 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on March 10, 2026 subject to the reporting person's continued service through such date.

2. Includes 587 shares acquired under the Genpact Employee Stock Purchase Plan (ESPP) since the reporting person's Form 4 filed on February 3, 2026. The reporting person currently holds a total of 8,962 shares under the ESPP.

3. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.74 to $40.771. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

4. The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Genpact (G) CEO Balkrishan Kalra report?

Genpact CEO Balkrishan Kalra reported an option exercise, a share sale, and a stock grant. He exercised 2,800 options, received 2,800 common shares, sold 2,800 shares in the market, and separately was granted 27,160 common shares as a stock award.

How many Genpact (G) shares did the CEO sell and at what price?

The CEO sold 2,800 Genpact common shares in an open‑market transaction. The weighted average sale price was $40.77 per share, with actual prices ranging from $40.74 to $40.771 according to the weighted‑average pricing footnote included in the filing.

How many Genpact (G) shares does the CEO hold after these transactions?

After the reported transactions, the CEO directly holds 525,007 Genpact common shares. This figure reflects the exercise of 2,800 options, the grant of 27,160 shares, and the sale of 2,800 shares, as disclosed in the post‑transaction ownership columns.

What stock awards did the Genpact (G) CEO receive in this Form 4?

The CEO received 27,160 Genpact common shares as a grant or award at no cost. Additionally, a prior grant of performance share units from March 15, 2023 is referenced, which will vest on March 10, 2026 if service conditions continue to be met.

What does the Form 4 say about Genpact (G) performance share units (PSUs)?

The filing notes PSUs granted to the CEO on March 15, 2023, with performance conditions already satisfied. Each PSU represents the right to receive one common share, and these PSUs are scheduled to vest on March 10, 2026, subject to continued service.

How many Genpact (G) shares does the CEO hold under the ESPP?

The CEO holds 8,962 Genpact shares under the Employee Stock Purchase Plan. This total includes 587 shares acquired under the ESPP since his prior Form 4 filed on February 3, 2026, as detailed in the footnote to the current Form 4.